Molecules 2016, 21, 1295
9 of 15
(m, 1H), 4.34–4.46 (m, 1H), 2.71 (dd, J = 7.7 and 17.3 Hz, 2H), 1.83–1.94 (m, 2H), 1.42–1.75 (m, 8H),
1.15–1.37 (m, 14 H), 0.84 (t, J = 6.8 Hz, 3 H); 13C-NMR (101 MHz, CDCl3):
= 136.8 (d, PCCCC = 3.0 Hz),
δ
J
134.4 (d, JPCC = 12.6 Hz), 128.5 (2C), 127.5, 126.1, 126.1, 119.7 (d, JPCCC = 9.4 Hz), 73.7 (d, JPOC = 7.0 Hz),
34.6 (d, JPC = 82.2 Hz), 34.2 (d, JPOCC = 5.6 Hz), 34.1, 31.8, 30.8 (d, JPCC = 15.1 Hz), 29.0, 29.0, 28.3 (d,
J
PC = 93.1 Hz), 25.2, 23.7 (2C), 22.6, 21.6 (d, JPCCC = 4.2 Hz), 14.1; HRMS (EI+) m/z calcd for C23H38O2P
([M + H]+) 377.2609, found 377.2531.
Butyl bis cinnamylphosphinate (Table 2, Entry 5). General procedure was used with cinnamyl alcohol
(0.13 mL, 1 mmol, 1 equiv.) and butyl cinnamyl-H-phosphinate (238 mg, 1 mmol, 1 equiv.). The crude
obtained was purified by column chromatography (hexane/ethyl acetate 50:50 to 0:100) to afford the
product as an orange oil (354 mg, 100%). 31P-NMR (CDCl3, 162 MHz)
400 MHz)
2H), 4.02 (dt, J = 6.8 and 7.0 Hz, 2H), 2.73 (dd, J = 7.6 and 17.5 Hz, 4H), 1.61 (quint., J = 7.2 Hz, 2H),
1.36 (sextuplet, J = 7.5 Hz, 2H), 0.88 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3):
= 136.7 (d,
PCCCC = 3.0 Hz, 2C), 135.0 (d, JPCC = 13.1 Hz, 2C), 128.6 (4C), 127.7 (2C), 126.2 (2C), 126.2 (2C), 118.9
δ
= 49.9 (s); 1H-NMR (CDCl3,
δ
= 7.21–7.33 (m, 8H), 7.14–7.20 (m, 2H), 6.45 (dd, J = 4.6 and 15.8 Hz, 2H), 6.11–6.22 (m,
δ
J
(d, JPCCC = 9.6 Hz, 2C), 64.6 (d, JPOC = 7.2 Hz), 33.3 (d, JPC = 88.7 Hz, 2C), 32.8 (d, JPOCC = 5.6 Hz), 18.8,
13.7; HRMS (EI+) m/z calcd for C22H28O2P ([M + H]+) 355.1827, found 355.1831.
Butyl 2-[(4-methoxyphenyl)ethyl] cinnamylphosphinate (Table 2, Entry 6). General procedure was used with
cinnamyl alcohol (0.13 mL, 1 mmol, 1 equiv.) and butyl 2-[4-methoxyphenyl)ethyl]-H-phosphinate
(256 mg, 1 mmol, 1 equiv.). The crude obtained was purified by column chromatography (hexane/ethyl
acetate 100:0 to 0:100) to afford the product as an orange oil (261 mg, 70%). 31P-NMR (CDCl3, 162 MHz)
δ
= 52.3 (s); 1H-NMR (CDCl3, 400 MHz)
δ = 7.29–7.38 (m, 4H), 7.22–7.28 (m, 1H), 7.10–7.15 (m, 2H),
6.81–6.87 (m, 2H), 6.45 (dd, J = 4.6 and 15.8 Hz, 1H), 6.11–6.22 (m, 1H), 4.06 (dt, J = 6.6 and 6.7 Hz, 2H),
3.78 (s, 3H), 2.83–2.99 (m, 2H), 2.73 (ddd, J = 0.7, 7.2 and 16.8 Hz, 2H), 2.01–2.12 (m, 2H), 1.68 (quint.,
J = 7.5 Hz, 2H), 1.43 (sextuplet, J = 7.5 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3):
δ
= 158.2, 136.7 (d, JPCCCC = 3.2 Hz), 134.8 (d, JPCCC = 12.9 Hz), 133.0 (d, JPCC = 14.6 Hz), 129.1 (2C),
128.6 (2C), 127.7, 126.2, 126.2, 119.1 (d, JPCCC = 9.4 Hz, 2C), 114.0 (2C), 64.4 (d, JPOC = 7.0 Hz), 55.3, 34.0
(d, JPC = 86.0 Hz), 32.8 (d, JPOCC = 5.7 Hz), 29.7 (d, JPC = 90.4 Hz), 27.0 (d, JPCC = 3.5 Hz), 18.9, 13.7;
HRMS (EI+) m/z calcd for C22H29O3P ([M + H]+) 373.1933, found 373.1855.
Butyl (2-ethylphthalimide) cinnamylphosphinate (Table 2, Entry 7). General procedure was used with
cinnamyl alcohol (1.7 mL, 12.94 mmol, 1 equiv.) and butyl (2-ethylphthalimide)-H-phosphinate
(3.3 g, 12.94 mmol, 1 equiv.). The crude obtained was purified by column chromatography
(dichloromethane/acetone 100:0 to 90:10) to afford the product as an orange oil (4.87 g, 100%).
31P-NMR (CDCl3, 162 MHz) δ = 49.1 (s); 1H-NMR (CDCl3, 400 MHz) δ = 7.82–7.90 (m, 2H), 7.68–7.75
(m, 2H), 7.20–7.44 (m, 5H), 6.62 (dd, J = 4.7 and 15.8 Hz, 1H), 6.16–6.27 (m, 1H), 3.95–4.12 (m, 4H),
2.88 (dd, J = 7.5 and 17.5 Hz, 2H), 2.17–2.34 (m, 2H), 1.58 (quint., J = 7.1 Hz, 2H), 1.35 (sextuplet,
J = 7.4 Hz, 2H), 0.89 (t, J = 7.4 Hz, 3H); 13C-NMR (101 MHz, CDCl3):
JPCCCC 3.2 Hz), 135.3 (d, PCC = 13.1 Hz), 134.1 (2C), 132.0 (2C), 128.6 (2C), 127.7, 126.3, 126.3, 123.4
δ = 167.8 (2C), 136.6 (d,
=
J
(2C), 118.5 (d, JPCCC = 9.6 Hz), 64.6 (d, JPOC = 7.0 Hz), 33.7 (d, JPC = 88.4 Hz), 32.6 (d, JPCC = 5.9 Hz),
31.7, 26.5 (d, JPC = 89.7 Hz), 18.8, 13.6; HRMS (EI+) m/z calcd for C23H27NO4P ([M + H]+) 412.1678,
found 412.1676.
Butyl (acetoxymethyl) cinnamylphosphinate (Table 2, Entry 8). General procedure was used with cinnamyl
alcohol (0.13 mL, 1 mmol, 1 equiv.) and butyl (acetoxymethyl)-H-phosphinate (194 mg, 1 mmol,
1 equiv.). The crude obtained was purified by column chromatography (hexane/ethyl acetate 100:0 to
0:100) to afford the product as an orange oil (239 mg, 77%). 31P-NMR (CDCl3, 162 MHz) δ = 43.6 (s)
;
1H-NMR (CDCl3, 400 MHz)
δ = 7.27–7.32 (m, 2H), 7.21–7.27 (m, 2H), 7.14–7.20 (m, 1H), 6.50 (dd, J = 5.0
and 15.9 Hz, 1H), 6.06–6.17 (m, 1H), 4.43 (dd, J = 7.8 and 14.5 Hz, 1H), 4.27 (dd, J = 4.2 and 14.5 Hz, 1H),
4.03 (dm, J = 39.6 Hz, 2H), 2.79 (ddd, J = 1.0, 7.7 and 18.5 Hz, 2H), 2.03 (s, 3H), 1.60 (quint., J = 7.5 Hz,